Cost-effectiveness analysis of imidapril compared to metoprolol in the treatment of stage 1 essential hypertension among Filipino patients seen at the Philippine General Hospital / (Record no. 2804)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02084nam a22002057a 4500 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | DOH |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20210211113836.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 210211b ||||| |||| 00| 0 eng d |
| 245 00 - TITLE STATEMENT | |
| Title | Cost-effectiveness analysis of imidapril compared to metoprolol in the treatment of stage 1 essential hypertension among Filipino patients seen at the Philippine General Hospital / |
| Statement of responsibility, etc. | He Wentian [two others] |
| 520 3# - SUMMARY, ETC. | |
| Summary, etc. | OBJECTIVE: To evaluate the cost-effectiveness of imidapril versus metoprolol as monotherapy in Filipino patients with Stage 1 essential hypertension.<br/><br/><br/>STUDY DESIGN: Cost-effectiveness analysis from the perspective of the health care payer.<br/><br/><br/>METHOD: Medical records of 94 out-patients aged 40-70 years old, with Stage 1 essential hypertension and follow-up treatment of 3 months at the Philippine General Hospital were reviewed. Effectiveness of each drug was based on: 1) percentage of patients achieving target blood pressure (< 140 / 90 mmHg); and 2) mean reduction of systolic and diastolic blood pressure. Cost-effectiveness of each drug was evaluated using the criteria of cost-effectiveness ratio (CER) and the incremental cost-effectiveness ratio (ICER).<br/><br/><br/>RESULTS: The mean cost of treatment with metoprolol was significantly lower than imidapril. However, treatment with imidapril resulted in a statistically significantly better blood pressure control compared to metoprolol; 77 percent of those given imidapril achieved the target BP vs 56 percent for metoprolol (p=0.03). CER and the ICER showed that 3-months treatment with metoprolol is more cost-effective than the use of imidapril.<br/><br/><br/>CONCLUSION: Use of metoprolol over a 3-month period is more cost-effective than imidapril in the treatment of Filipino patients with Stage 1 essential hypertension. |
| 580 ## - LINKING ENTRY COMPLEXITY NOTE | |
| Linking entry complexity note | In: Acta Medica Philippina, 2006 vol. 40 (1) pages: 29-36 |
| 650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Metoprolol |
| 650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Hypertension |
| General subdivision | therapy |
| 653 ## - INDEX TERM--UNCONTROLLED | |
| Uncontrolled term | Imidapril |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Wentian, He |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Jimeno, Cecilia A. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Panelo, Carlo Irwin A. |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Koha item type | Journal Article |
| 999 ## - | |
| -- | 2804 |
| -- | 2804 |
| Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Home library | Current library | Shelving location | Date acquired | Total Checkouts | Full call number | Barcode | Date last seen | Price effective from | Koha item type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| National Library of Medicine | DOH Central Library | DOH Central Library | Electronic Resource Section | 02/11/2021 | J000020 | D0001J000020 | 02/11/2021 | 02/11/2021 | Journal Article |